azomycin has been researched along with Cirrhoses, Experimental Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corpechot, C; Galy, B; Housset, C; Poupon, R; Raleigh, J; Rosmorduc, O; Sebbagh, N; Wendum, D | 1 |
| Barbu, V; Chignard, N; Corpechot, C; Housset, C; Poupon, R; Rosmorduc, O; Wendum, D | 1 |
2 other study(ies) available for azomycin and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis.
Topics: Animals; Blotting, Western; Cell Hypoxia; Endothelial Growth Factors; Fibroblast Growth Factor 2; Immunohistochemistry; Ki-67 Antigen; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Lymphokines; Male; Neovascularization, Pathologic; Nitroimidazoles; Protein Isoforms; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1999 |
Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosis.
Topics: Animals; Cell Hypoxia; Cells, Cultured; Cyclic AMP; Hepatocyte Growth Factor; Hepatocytes; Humans; Liver; Liver Cirrhosis, Experimental; Male; Nitroimidazoles; Proto-Oncogene Proteins c-met; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Regeneration; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2002 |